Escitaloprám use
Pro Research Analysisby 
Searched over 200M research papers for "escitaloprám use"
Escitalopram Use: A Comprehensive Overview
Escitalopram for Impulsive-Compulsive Internet Usage Disorder
Treatment Efficacy and Safety
Escitalopram has shown promise in treating impulsive-compulsive internet usage disorder (IC-IUD), characterized by excessive internet use that disrupts daily life. In a study involving 19 adults, escitalopram significantly reduced internet usage from 36.8 hours per week to 16.5 hours per week over a 10-week period. Additionally, 64.7% of participants reported significant improvement in their condition . However, during a subsequent double-blind phase, no significant differences were observed between the escitalopram and placebo groups, suggesting that the initial gains were maintained regardless of continued medication .
Escitalopram in Adolescent Depression
Short-Term and Extended Efficacy
In adolescents with major depressive disorder (MDD), escitalopram has been found effective. A randomized, placebo-controlled trial with 312 participants aged 12-17 showed significant improvement in depression scores for those treated with escitalopram compared to placebo over 8 weeks . An extension of this study over 24 weeks confirmed that escitalopram continued to provide significant improvements in depression symptoms and higher remission rates compared to placebo .
Safety and Tolerability
The treatment was generally well-tolerated, with common side effects including headache, menstrual cramps, insomnia, and nausea. Serious adverse events were rare and comparable between the escitalopram and placebo groups Emslie2009Findling2013.
Escitalopram for Generalized Anxiety Disorder
Clinical Efficacy
Escitalopram has also been effective in treating generalized anxiety disorder (GAD). In a study with 315 participants, those treated with escitalopram showed significant improvement in anxiety symptoms compared to placebo, starting as early as the first week of treatment and continuing throughout the 8-week study period . The response rate was significantly higher for escitalopram (68%) compared to placebo (41%) .
Tolerability
The medication was well-tolerated, with adverse events such as nausea and insomnia being mild and transient. The discontinuation rate due to adverse events was not significantly different from placebo .
Escitalopram for Social Anxiety Disorder
Meta-Analysis Findings
A meta-analysis of randomized, placebo-controlled trials involving 1,598 patients with social anxiety disorder (SAD) demonstrated that escitalopram significantly reduced anxiety symptoms compared to placebo. The improvement was consistent across various doses (5mg, 10mg, and 20mg per day) . The withdrawal rate due to adverse events was slightly higher for escitalopram compared to placebo, but the overall tolerability was acceptable .
Escitalopram in Geriatric Depression with Cognitive Complaints
Combined Treatment with Memantine
In older adults with depression and cognitive complaints, a combination of escitalopram and memantine was tested. The combination was as effective as escitalopram alone in improving depression but showed greater benefits in cognitive functions such as delayed recall and executive functioning over a 12-month period . This suggests potential added benefits for cognitive health when combining escitalopram with memantine in this population .
Conclusion
Escitalopram is a versatile SSRI with proven efficacy in treating various conditions, including impulsive-compulsive internet usage disorder, adolescent and geriatric depression, generalized anxiety disorder, and social anxiety disorder. It is generally well-tolerated, with mild and transient side effects. While it shows significant benefits in short-term and extended use, further research is needed to explore its long-term efficacy and safety across different populations and in combination with other treatments.
Sources and full results
Most relevant research papers on this topic
DOI
DOI
DOI